1Frutos MA, Martin Gomez A, de Ramon E, et al. Intravenous eyclophosphamide in lupus nephritis: twenty years reducing dose. Nefrologia, 2007,27(1) : 12 - 22.
2Grootscholten C, Ligtenberg G, Hagen EC, et al. Azathioprine/ methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial. Kidney Int, 2006, 70(4) :732 - 742.
3Grootscholten C,Bajema IM, Florquin S, et al. Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis. Arthritis Rheum, 2007,56 (3) : 924 - 937.
4Benenson E, Fries JW, Heilig B, et al. High- dose azathioprine pulse therapy as a new treatment option in patients with active Wegener's granulomatosis and lupus nephritis refractory or intolerant to cyclophosphamide. Clin Rheumatol, 2005,24 (3) : 251 - 257.
5Suria S, Checa MD. Mycophenolate mofetil in the treatment of lupus nephritis, in patients with failure, intolerance or relapses after treatment with steroids and cyclophospharnide. Nefrologia, 2007,27 (4) : 459 - 465.
6Ginzler EM, Dooley MA, Aranow C, et al. Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis. N Engl J Med,2005,353(21 ) :2219 - 2228.
7Wilson EC, Jayne DR, Dellow E, et al. The cost - effectiveness of myeophenolate mofetil as firstline therapy in active lupus nephritis. Rheumatology (Oxford), 2007,46 (7) : 1096 - 1101.
8Contreras G, Pardo V, Leclercq B, et al. Sequential therapies for proliferative lupus nephritis. N Engl J Med, 2004,350 (10) : 971 - 980.
9Momni G, Doria A, Mosca M, et al. A randomized pilot trial comparing eyelosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years. Clin J Am Soc Nephrol,2006,1(5) :925 - 932.
10Wang HY,Cui TG, Hou FF,et al. Induction treatment of proliferative lupus nephritis with leflunomide combined with pred-nisone: a prospective multi- centre observational study. Lupus, 2008,17(7) :638 - 644.
同被引文献16
1Matsuki Y,Suzuki K,Kawakami M,et al.High-avidity antiDNA antibody removal from the serum of systemic lupus erythematosus patientsadsorption using dextran sulfate cellulosecolumns.J Clin Apheresis,1996,11(1):30-35.
2叶任高.内科学[M].北京:人民卫生出版社,2000.721-723.
3Pavelko KD, Howe CL, Drescher KM, et al. lnterleukm-6 protects anterior horn neurons from lethal virus induced injury[J]. J Neu- rosei,2003,23(2) :481-492.